patent/WO-0002874-A3

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2020da546815dc1f1dd01fff1bafe851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb908d4685c3c5c35af036b202df0c07
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-83
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-83
filingDate	1999-07-09^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e7fe3c69723292b6a574213c57d74b
publicationDate	2000-02-24^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-0002874-A3
titleOfInvention	Integrin dependent cell adhesion inhibitors
abstract	The present invention relates to euparin derivatives having broad spectrum integrin receptor inhibition activity and utility in the treatment of integrin mediated disease.
priorityDate	1998-07-09^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9814440-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0132130-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9809956-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119039 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4640 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227862771 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543081 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394213

Showing number of triples: 1 to 20 of 20.